These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28833619)

  • 21. Hepatitis B virus eradication strategy for Asia. The Asian Regional Study Group.
    Sung JL
    Vaccine; 1990 Mar; 8 Suppl():S95-9. PubMed ID: 2139290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rotavirus vaccination: cost-effectiveness and impact on child mortality in developing countries.
    Atherly D; Dreibelbis R; Parashar UD; Levin C; Wecker J; Rheingans RD
    J Infect Dis; 2009 Nov; 200 Suppl 1():S28-38. PubMed ID: 19817610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The cost-benefit of interferon therapy in chronic viral liver diseases].
    Ascione A; De Luca M
    Minerva Gastroenterol Dietol; 1995 Mar; 41(1):123-5. PubMed ID: 7542483
    [No Abstract]   [Full Text] [Related]  

  • 24. Environmental contributions to gastrointestinal and liver cancer in the Asia-Pacific region.
    Ko KP; Shin A; Cho S; Park SK; Yoo KY
    J Gastroenterol Hepatol; 2018 Jan; 33(1):111-120. PubMed ID: 28960448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites.
    Kim SY; Billah K; Lieu TA; Weinstein MC
    Am J Prev Med; 2006 Jun; 30(6):498-506. PubMed ID: 16704944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Projected cost-effectiveness of rotavirus vaccination for children in Asia.
    Podewils LJ; Antil L; Hummelman E; Bresee J; Parashar UD; Rheingans R
    J Infect Dis; 2005 Sep; 192 Suppl 1():S133-45. PubMed ID: 16088797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted outreach hepatitis B vaccination program in high-risk adults: The fundamental challenge of the last mile.
    Mangen MJ; Stibbe H; Urbanus A; Siedenburg EC; Waldhober Q; de Wit GA; van Steenbergen JE;
    Vaccine; 2017 May; 35(24):3215-3221. PubMed ID: 28483198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific Region.
    Amarapurkar D; Han KH; Chan HL; Ueno Y;
    J Gastroenterol Hepatol; 2009 Jun; 24(6):955-61. PubMed ID: 19383082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overview of hepatitis B prevalence, prevention, and management in the Pacific Islands and Territories.
    Howell J; Van Gemert C; Lemoine M; Thursz M; Hellard M
    J Gastroenterol Hepatol; 2014 Nov; 29(11):1854-66. PubMed ID: 25131570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries.
    Das A
    Hepatology; 1999 Feb; 29(2):548-52. PubMed ID: 9918934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-benefit analysis of a nationwide inoculation programme against viral hepatitis B in an area of intermediate endemicity.
    Ginsberg GM; Berger S; Shouval D
    Bull World Health Organ; 1992; 70(6):757-67. PubMed ID: 1486673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of the microbiome and the use of probiotics in gastrointestinal disorders in adults in the Asia-Pacific region - background and recommendations of a regional consensus meeting.
    Ghoshal UC; Gwee KA; Holtmann G; Li Y; Park SJ; Simadibrata M; Sugano K; Wu K; Quigley EMM; Cohen H
    J Gastroenterol Hepatol; 2018 Jan; 33(1):57-69. PubMed ID: 28589613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness analysis of the national Perinatal Hepatitis B Prevention Program.
    Barbosa C; Smith EA; Hoerger TJ; Fenlon N; Schillie SF; Bradley C; Murphy TV
    Pediatrics; 2014 Feb; 133(2):243-53. PubMed ID: 24394684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of health systems strengthening interventions in improving maternal and child health in low- and middle-income countries: a systematic review.
    Zeng W; Li G; Ahn H; Nguyen HTH; Shepard DS; Nair D
    Health Policy Plan; 2018 Mar; 33(2):283-297. PubMed ID: 29253136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness analysis of an additional birth dose of Hepatitis B vaccine to prevent perinatal transmission in a medical setting in Mozambique.
    Klingler C; Thoumi AI; Mrithinjayam VS
    Vaccine; 2012 Dec; 31(1):252-9. PubMed ID: 22902676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of rotavirus vaccination as part of the national immunization program for Thai children.
    Chotivitayatarakorn P; Chotivitayatarakorn P; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2010 Jan; 41(1):114-25. PubMed ID: 20578490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economic analysis of promotion of hepatitis B vaccinations among Vietnamese-American children and adolescents in Houston and Dallas.
    Zhou F; Euler GL; McPhee SJ; Nguyen T; Lam T; Wong C; Mock J
    Pediatrics; 2003 Jun; 111(6 Pt 1):1289-96. PubMed ID: 12777543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening.
    Robotin MC; Kansil M; Howard K; George J; Tipper S; Dore GJ; Levy M; Penman AG
    J Hepatol; 2009 May; 50(5):990-8. PubMed ID: 19303657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cost effectiveness of hepatitis immunization for US college students.
    Jacobs RJ; Saab S; Meyerhoff AS
    J Am Coll Health; 2003 May; 51(6):227-36. PubMed ID: 14510025
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.